Innovative therapeutics for inflammatory bowel disease

Yazar: Yamamoto-Furusho, Jesus K
Baskı/Yayın Bilgisi 2007

Genetic factors associated with the development of inflammatory bowel disease

Yazar: Yamamoto-Furusho, Jesus K
Baskı/Yayın Bilgisi 2007

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies

Yazar: Yamamoto-Furusho, Jesús K
Yayımlandı Pharmgenomics Pers Med (2017)

New treatment options in the management of IBD – focus on colony stimulating factors

Yazar: Barahona-Garrido, Josué, Yamamoto-Furusho, Jesús K
Baskı/Yayın Bilgisi 2008

Crohn’s disease: Innate immunodeficiency?

Yazar: Yamamoto-Furusho, Jesus K, Korzenik, Joshua R
Baskı/Yayın Bilgisi 2006

Innate immunity in inflammatory bowel disease

Yazar: Yamamoto-Furusho, Jesus K, Podolsky, Daniel K
Baskı/Yayın Bilgisi 2007

Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study

Yazar: Yamamoto-Furusho, Jesús K, Sarmiento-Aguilar, Andrea
Yayımlandı Can J Gastroenterol Hepatol (2015)

Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis

Yazar: Yamamoto-Furusho, Jesús K., Mendieta-Escalante, Erick A.
Yayımlandı PLoS One (2020)

Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country

Yazar: Yamamoto-Furusho, Jesús K., Sánchez-Morales, Germán E.
Yayımlandı Inflamm Intest Dis (2020)

Role of cytokines in inflammatory bowel disease

Yazar: Sanchez-Muñoz, Fausto, Dominguez-Lopez, Aaron, Yamamoto-Furusho, Jesus K
Baskı/Yayın Bilgisi 2008

Basic and clinical aspects of osteoporosis in inflammatory bowel disease

Yazar: Rodríguez-Bores, Lorena, Barahona-Garrido, Josué, Yamamoto-Furusho, Jesús K
Baskı/Yayın Bilgisi 2007

MDP-NOD2 stimulation induces HNP-1 secretion which contributes to NOD2 anti-bacterial function

Yazar: Yamamoto-Furusho, Jesus K., Barnich, Nicolas, Hisamatsu, Tadakazu, Podolsky, Daniel K.
Baskı/Yayın Bilgisi 2010

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry

Yazar: Sarmiento-Aguilar, Andrea, Ríos-Blancas, María J., Yamamoto-Furusho, Jesús K.
Yayımlandı Can J Gastroenterol Hepatol (2020)

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis

Yazar: Yamamoto-Furusho, Jesús K., Martínez-Benítez, Braulio, Sánchez-Morales, Germán E.
Yayımlandı Gastroenterol Res Pract (2020)

Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study

Yazar: Furuzawa-Carballeda, Janette, Fonseca-Camarillo, Gabriela, Lima, Guadalupe, Yamamoto-Furusho, Jesús K.
Baskı/Yayın Bilgisi 2013

Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis

Yazar: Yamamoto-Furusho, Jesus K, Uscanga-Domínguez, Luis, Lopez-Martinez, Alondra, Granados, Julio
Baskı/Yayın Bilgisi 2006

Growth Factors as Treatment for Inflammatory Bowel Disease: A Concise Review of the Evidence Toward Their Potential Clinical Utility

Yazar: Barahona-Garrido, Josué, Hernández-Calleros, Jorge, García-Juárez, Ignacio, Yamamoto-Furusho, Jesús K.
Baskı/Yayın Bilgisi 2009

Novel genetic markers in inflammatory bowel disease

Yazar: Rodríguez-Bores, Lorena, Fonseca, Gabriela C, Villeda, Marco A, Yamamoto-Furusho, Jesús K
Baskı/Yayın Bilgisi 2007

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire

Yazar: Bueno-Hernández, Nallely, Núñez-Aldana, Martha, Ascaño-Gutierrez, Ilse, Yamamoto-Furusho, Jesús K
Yayımlandı Nutr J (2015)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis

Yazar: Yamamoto-Furusho, Jesús K., Ascaño-Gutiérrez, Ilse, Furuzawa-Carballeda, Janette, Fonseca-Camarillo, Gabriela
Yayımlandı Mediators Inflamm (2015)